Endocrine Disruptors

ECHA Call for Evidence on Including Endocrine Disruptors in the CMRD

ECHA has launched a call for evidence to evaluate incorporating endocrine disruptors into the Carcinogens, Mutagens and Reprotoxic Substances Directive (CMRD). Inclusion would likely subject endocrine disruptors to the EU's strictest occupational exposure limits, requiring manufacturers to reassess workplace safety protocols and substance risk profiles.

8 Apr 2026, 15:58echa.europa.euEuropean Union

New York Senate Introduces Bill to Ban Bisphenol A in Business Transaction Paper

New York has introduced legislation to ban Bisphenol A (BPA) in all business transaction paper, including receipts and banking records, effective 180 days after enactment. Companies must evaluate thermal paper supply chains and prepare for a transition to state-certified "least toxic" alternatives to avoid non-compliance and hazardous substitution risks.

6 Apr 2026, 16:51nysenate.govUnited States

Belgium Launches National Endocrine Disruptor Awareness Campaign for Parents and Health Professionals

Belgium has launched a national awareness campaign targeting endocrine disruptors in consumer products, specifically focusing on risks to infants and pregnant women. This initiative signals increasing public and regulatory scrutiny of plastic additives and fragrances, likely driving consumer demand for 'clean' alternatives and foreshadowing stricter enforcement or future restrictions.

5 Apr 2026, 18:58departementzorg.beBelgium

European Parliament Committees Propose SDG Amendments Calling For PFAS Phase-Out And Endocrine Disruptor Ban

European Parliament committees have proposed amendments to the SDG implementation report calling for a phase-out of PFAS and a ban on endocrine disruptors. While non-binding, these proposals signal strong political pressure to accelerate chemical restrictions under the Zero Pollution agenda and the Water Resilience Strategy.

5 Apr 2026, 05:59europarl.europa.euEuropean Union

US Researchers Report PFDA Mechanism Disrupting Foetal Craniofacial Development

New mechanistic evidence links the long-chain PFAS perfluorodecanoic acid (PFDA) to fetal developmental defects through retinoic acid pathway disruption. This data strengthens the case for stricter hazard classifications and targeted regulatory screening of long-chain PFAS in ongoing human health risk assessments.

5 Apr 2026, 05:26pubs.acs.orgUnited States

Netherlands (RIVM) Adds SVHC and Endocrine-Disrupting Pesticides to Zeer Zorgwekkende Stoffen List (March 2026)

The Netherlands expanded its national list of Substances of Very High Concern (ZZS) in March 2026, adding 18 chemicals including n-hexane and various endocrine-disrupting pesticides. Dutch operators must now review permits and prioritize emission minimization or substitution to align with strict national environmental requirements that often exceed EU REACH standards.

5 Apr 2026, 04:55rvs.rivm.nlNetherlands

EFSA Peer Review of Isoxaflutole Endocrine-Disruptor Confirmatory Data Under Regulation 844/2012

EFSA has commenced a peer review of confirmatory endocrine-disrupting data for isoxaflutole following the receipt of an evaluation report in March 2026. This assessment is a critical hurdle for the herbicide's renewal, as confirmed endocrine-disrupting properties could lead to severe use restrictions or the loss of EU market authorization.

3 Apr 2026, 09:52open.efsa.europa.euEuropean Union

ECHA CLH Dossier Submitted for 1,1,2,2,3,3,4,4,4-Nonafluorobutane-1-Sulphonic Acid

Norway submitted a harmonised classification proposal for the PFAS substance PFBS to ECHA in March 2026. The proposed status as an endocrine disruptor and persistent/mobile substance (PMT/vPvM) signals heightened regulatory risk and likely future restrictions for short-chain PFAS.

1 Apr 2026, 19:31echa.europa.euEuropean Union

ECHA Schedules 2026 Science Seminar, IUCLID 6 Webinar and Drinking Water Directive Workshops

ECHA has announced its 2026 technical schedule, highlighting the IUCLID 6 version 10 release and implementation workshops for the Drinking Water Directive. Stakeholders must prepare for updated data submission formats and the operationalization of the European positive list for materials in contact with drinking water.

31 Mar 2026, 19:08echa.europa.euEuropean Union

Commission Expert Group on Implementation of the Drinking Water Directive – 19th Meeting (23 April 2026)

The European Commission's Drinking Water Directive expert group will meet in April 2026 to review implementation progress and technical studies on PFAS, Bisphenol A, and pesticide metabolites. Discussions regarding parametric values and the feasibility of an Extended Producer Responsibility (EPR) system signal potential new cost-sharing obligations and stricter monitoring requirements for chemical manufacturers.

29 Mar 2026, 17:28ec.europa.euEuropean Union

HEAL Supports French Proposal to Classify Medium-Chain Ortho-Phthalates as Reproductive Toxicants and Endocrine Disruptors

HEAL has supported a French proposal to classify 48 medium-chain ortho-phthalates as reproductive toxicants and endocrine disruptors under EU CLP. This signals a shift toward group-based regulatory action and additive toxicity assessments, likely leading to broader REACH restrictions and stricter safety requirements for plastic-containing products.

29 Mar 2026, 05:45env-health.orgEuropean UnionFrance

EU Expert Group Meeting Reviews Biocidal Products Regulation Implementation, ED Guidance And Microplastics Restriction

EU regulators have formalised updates to Biocidal Products Regulation (BPR) implementation, targeting stricter IUCLID dossier formats and the integration of REACH microplastics restrictions into product authorisations. Companies must prepare for mandatory dossier resubmissions starting July 2026 and assess the strategic impact of new endocrine disruptor guidance on active substance renewals and product compliance.

28 Mar 2026, 18:48health.ec.europa.euEuropean Union

EFSA Develops Adverse Outcome Pathway Network for Reproductive Toxicity to Support Endocrine Disruptor Identification

EFSA published a new toxicological framework in March 2026 to standardize endocrine disruptor identification under EU biocides and pesticides regulations. This signals a shift toward mechanistic data and New Approach Methodologies (NAMs), increasing the technical requirements for demonstrating substance safety in reproductive toxicity assessments.

28 Mar 2026, 17:02efsa.europa.euEuropean Union

EU Adopts Directive Updating Water Pollutant Standards and Adding PFAS and Microplastics

The EU has formally adopted a directive tightening water quality standards, adding PFAS, microplastics, and pharmaceuticals to regulated pollutant lists with a December 2027 transposition deadline. This expansion will trigger stricter industrial discharge permits and monitoring requirements, requiring long-term compliance planning for chemical, pharmaceutical, and agricultural operators.

28 Mar 2026, 16:00data.consilium.europa.euEuropean Union

European Commission JRC Publishes Methodology for Selecting Substances for the Groundwater Watch List

The European Commission’s Joint Research Centre (JRC) has finalized a new methodology for selecting substances for the Groundwater Watch List, identifying high-priority candidates for future EU-wide monitoring. This framework signals a shift toward stricter groundwater oversight for azole fungicides, antibiotics, and PFAS, likely leading to new environmental quality standards and increased reporting burdens for chemical and pharmaceutical manufacturers.

27 Mar 2026, 19:42publications.jrc.ec.europa.euEuropean Union

EU/France: HEAL Supports REACH Proposal To Restrict Octocrilene In Cosmetic Products

HEAL has formally supported the proposed EU REACH restriction on octocrilene in cosmetics, advocating for a shortened two-year transition period. This development signals strong NGO pressure for a rapid phase-out, requiring manufacturers to accelerate reformulation efforts and assess the environmental profile of potential alternatives.

27 Mar 2026, 18:41env-health.orgEuropean UnionFrance

France Highlights One Health Strategy To Tackle Plastic Pollution

France is positioning plastic pollution as a central "One Health" priority, signaling intensified enforcement of the AGEC Law and a push for a binding global plastics treaty. Companies should anticipate stricter eco-design mandates and expanded EPR schemes as regulators increasingly link plastic additives and microplastics to systemic human health risks.

27 Mar 2026, 18:17ecologie.gouv.frFrance

EU Mandate to EFSA for Peer Review of Cyazofamid Endocrine Disruption Data (EFSA-Q-2025-00577)

EFSA has initiated a peer review of confirmatory endocrine disruption data for the fungicide cyazofamid, with a technical outcome expected by September 2026. The findings will be critical in determining the substance's long-term regulatory standing and could lead to future restrictions or non-renewal of its EU authorization.

27 Mar 2026, 08:27open.efsa.europa.euEuropean Union

EU CA Meeting Reviews Progress of BPR Active Substance Review and Renewal Programme (March 2026)

The EU has signaled a critical need to accelerate the BPR active substance review programme to clear a significant backlog before the 2030 deadline. Manufacturers face increased risk of sudden market exits for substances failing renewal, alongside stricter scrutiny of endocrine-disrupting impurities that could trigger mandatory substitution.

26 Mar 2026, 19:31circabc.europa.euEuropean Union

European Commission Outlines Targeted REACH Revision Plans in Reply to Dutch Parliament

The European Commission has confirmed plans for a targeted REACH revision to simplify procedures and transition from individual authorizations toward broader substance restrictions. This shift indicates a more aggressive regulatory pace, requiring businesses to prepare for stricter enforcement mechanisms and expanded data requirements for endocrine disruptors.

26 Mar 2026, 11:43zoek.officielebekendmakingen.nlEuropean Union